Watts MJ - Search Results

1

Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.

Ancliff PJ, Gale RE, Watts MJ, Liesner R, Hann IM, Strobel S, Linch DC. Ancliff PJ, et al. Among authors: watts mj. Blood. 2002 Jul 15;100(2):707-9. doi: 10.1182/blood-2002-01-0060. Blood. 2002. PMID: 12091371 Free article.

2

Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation.

Williams CD, Linch DC, Watts MJ, Thomas NS. Williams CD, et al. Among authors: watts mj. Blood. 1997 Jul 1;90(1):194-203. Blood. 1997. PMID: 9207453 Free article.

3

Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: selective regulation by stem cell factor involving the MAP kinase pathway.

Roberts PJ, Mollapour E, Watts MJ, Linch DC. Roberts PJ, et al. Among authors: watts mj. Blood. 1999 Aug 15;94(4):1261-72. Blood. 1999. PMID: 10438714 Free article.

4

Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31).

Yong KL, Watts M, Shaun Thomas N, Sullivan A, Ings S, Linch DC. Yong KL, et al. Blood. 1998 Feb 15;91(4):1196-205. Blood. 1998. PMID: 9454749 Free article.

5

Optimisation and quality control of cell processing for autologous stem cell transplantation.

Watts MJ, Linch DC. Watts MJ, et al. Br J Haematol. 2016 Dec;175(5):771-783. doi: 10.1111/bjh.14378. Epub 2016 Oct 17. Br J Haematol. 2016. PMID: 27748518 Free article. Review.

6

Standards for PBSC mobilisation and collection.

Linch DC, Watts MJ. Linch DC, et al. Among authors: watts mj. Ann Oncol. 1996;7 Suppl 2:9-10. doi: 10.1093/annonc/7.suppl_2.9. Ann Oncol. 1996. PMID: 8805942 Free article. Review. No abstract available.

7

Peripheral blood stem cell transplantation.

Watts MJ, Linch DC. Watts MJ, et al. Vox Sang. 1997;73(3):135-42. doi: 10.1046/j.1423-0410.1997.7330135.x. Vox Sang. 1997. PMID: 9358614 Review.

8

Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices.

Watts MJ, Somervaille TC, Ings SJ, Ahmed F, Khwaja A, Yong K, Linch DC. Watts MJ, et al. Br J Haematol. 2002 Jul;118(1):117-23. doi: 10.1046/j.1365-2141.2002.03561.x. Br J Haematol. 2002. PMID: 12100134 Free article.

9

Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.

Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ. Ings SJ, et al. Among authors: watts mj. Br J Haematol. 2006 Sep;134(5):517-25. doi: 10.1111/j.1365-2141.2006.06223.x. Br J Haematol. 2006. PMID: 17018030 Free article.

10

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma.

Watts MJ, Sullivan AM, Jamieson E, Pearce R, Fielding A, Devereux S, Goldstone AH, Linch DC. Watts MJ, et al. J Clin Oncol. 1997 Feb;15(2):535-46. doi: 10.1200/JCO.1997.15.2.535. J Clin Oncol. 1997. PMID: 9053475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters